Creoptix
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Einsiedlerstrasse 34, Wädenswil, Zurich,...Phone Number
+41 445332660Website
www.creoptix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Creoptix
Creoptix, a brand of Malvern Panalytical, specializes in providing advanced tools for molecular interaction analysis aimed at life scientists. Their flagship product, the Creoptix WAVE, offers high sensitivity and resolution for studying real-time biological interactions, facilitating drug discovery and research in both industry and academia. The company focuses on next-generation bioanalytical instruments and technologies, including proprietary biosensors and microfluidics. With a commitment to accelerating discovery, Creoptix supports researchers with innovative software and chips designed for enhanced data quality and sample compatibility.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Creoptix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Creoptix, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Creoptix launches new products
Funding: Get notified immidiatlly once Creoptix has new funding data
Earning: See what the market has to say on Creoptix recently announced quarterly report
Check if Creoptix has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Creoptix
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Creoptix is spiking on competitors!
Click to see if Creoptix had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Creoptix as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Creoptix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Creoptix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Creoptix.
Creoptix Tech Stack
A closer look at the technologies used by Creoptix
Creoptix News & Media
Creoptix launches waveRAPID[®] – a new and faster way of measuring kinetics to accelerate drug discovery
Wädenswil/Zurich, Switzerland, 2 February 2021 – Creoptix AG (https://www.creoptix.com/), a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the launch of waveRAPID[®] (https://www.creoptix.com/knowledge-center/resources/events/waverapid-launch) (Repeated Analyte Pulses of Increasing Duration), a novel, label-free kinetic measurement method that is faster than traditional kinetics. The company developed and commercializes the Creoptix[®] WAVEsystemDomainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform
Wädenswil/Zurich, Switzerland, and Saffron Walden, UK, 12 January 2021 – Domainex Ltd. (https://www.domainex.co.uk/), a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG (https://www.creoptix.com/). This instrument utilizes Grating-Coupled Interferometry (https://www.domainex.co.uk/services/biophysics/surface-plasmon-resonance-SPR-and-GCI) (GCI) to measure target binding on sensor chips, generating binCreoptix and oneservice partner for WAVEsystem after-sales support
Wädenswil/Zurich, Switzerland, 25 November 2020 – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced that it has signed an agreement with oneservice AG, a global provider of specialty technical services, to offer after-sales support and services for its ground-breaking WAVEsystem in Europe and the US. Creoptix’ WAVEsystem is a label-free biosensor used in life sciences research to study molecular interactions in real-time. Based on prop2bind and Creoptix sign technology-service partnership
Zurich, Switzerland, and Regensburg, Germany, 17 November 2020 – Creoptix and 2bind have signed a technology-service partnership, which enables both parties to continue offering customers the highest quality research tools and help them accelerate their R&D. The collaboration supports 2bind to expand its service portfolio with the innovative WAVEsystem and provides Creoptix with a highly experienced partner as a certified service provider and beta-tester for future technology developments. 2bind
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Creoptix
Sign Up For FreeTo access detailed company insights
Creoptix, a brand of Malvern Panalytical, specializes in providing advanced tools for molecular interaction analysis aimed at life scientists. Their flagship product, the Creoptix WAVE, offers high sensitivity and resolution for studying real-time biological interactions, facilitating drug discovery and research in both industry and academia. The c... Read More
